Calyx and Qynapse Announce Partnership

Published on: July 25, 2022

Calyx announced it has entered into a partnership with Qynapse. The partnership enables Calyx to adopt and deliver Qynapse's AI-powered neuroimaging analysis solutions, QyScore® and QyPredict® to its global pharmaceutical and biotech customers as they develop new medical treatments for central nervous system (CNS) disorders.